home / stock / nite / nite quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $25.41 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 06/11/2019 09:43:06 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $25.41 | $N/A | $N/A | 0 | 06-11-2019 |
$ | $N/A | $25.41 | $N/A | $N/A | 0 | 06-10-2019 |
$ | $N/A | $25.41 | $N/A | $N/A | 40 | 06-07-2019 |
$ | $25.435 | $25.41 | $25.44 | $25.40 | 1,101,731 | 06-06-2019 |
$ | $25.49 | $25.42 | $25.49 | $25.3973 | 2,097,469 | 06-05-2019 |
$ | $25.49 | $25.49 | $25.50 | $25.48 | 36,555 | 06-04-2019 |
$ | $25.47 | $25.49 | $25.49 | $25.47 | 34,540 | 06-03-2019 |
$ | $25.47 | $25.49 | $25.49 | $25.46 | 16,979 | 05-31-2019 |
$ | $25.46 | $25.46 | $25.50 | $25.44 | 52,036 | 05-30-2019 |
$ | $25.47 | $25.48 | $25.48 | $25.44 | 41,426 | 05-29-2019 |
$ | $25.47 | $25.46 | $25.47 | $25.45 | 35,284 | 05-28-2019 |
$ | $25.50 | $25.47 | $25.50 | $25.435 | 45,854 | 05-27-2019 |
$ | $25.50 | $25.47 | $25.50 | $25.435 | 45,854 | 05-24-2019 |
$ | $25.50 | $25.50 | $25.50 | $25.44 | 32,657 | 05-23-2019 |
$ | $25.50 | $25.50 | $25.50 | $25.46 | 24,599 | 05-22-2019 |
$ | $25.45 | $25.48 | $25.50 | $25.45 | 6,644 | 05-21-2019 |
$ | $25.4862 | $25.44 | $25.49 | $25.42 | 6,157 | 05-20-2019 |
$ | $25.44 | $25.48 | $25.48 | $25.44 | 12,003 | 05-17-2019 |
$ | $25.48 | $25.44 | $25.48 | $25.44 | 60,568 | 05-16-2019 |
$ | $25.43 | $25.48 | $25.48 | $25.42 | 66,125 | 05-15-2019 |
News, Short Squeeze, Breakout and More Instantly...
Nightstar Therapeutics plc Company Name:
NITE Stock Symbol:
NASDAQ Market:
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION WALTHAM, Mass. and LONDON, June 07, 2019 (GLOBE NEWSWIRE...
CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) today announced that it has completed its acquisition of Nightstar Therapeutics (NST; Nasdaq: NITE), a clinical-stage gene therapy company, which is focused on adeno-associated virus (AAV) treatments for inherited ret...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION WALTHAM, Mass. and LONDON, June 05, 2019 (GLOBE NEWSWIRE...